SOTAC PHARMACEUTICALS LTD Share Price
SOTAC PHARMACEUTICALS LTD Share Price Today
As of 5 Jul 2026, SOTAC PHARMACEUTICALS LTD share price is ₹105.00. The stock opened at ₹105.00, compared to its previous close of ₹105.00. During today's trading session, SOTAC PHARMACEUTICALS LTD share price moved in the range of ₹105.00 to ₹105.00, with an average price of ₹105.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹100.00 and a high of ₹139.65. On the performance front, SOTAC PHARMACEUTICALS LTD share price has declined by 10.26% over the last six months and is down 23.13% on a year-on-year basis.
SOTAC PHARMACEUTICALS LTD Returns Calculator
SOTAC PHARMACEUTICALS LTD Shareholder Returns
SOTAC PHARMACEUTICALS LTD Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
SOTAC PHARMACEUTICALS LTD Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 |
|---|---|---|---|---|
| Revenue | ₹96.99 | ₹103.83 | ₹77.48 | ₹48.84 |
| Other Income | ₹3.90 | ₹0.49 | ₹0.35 | ₹0.11 |
| Total Revenue | ₹100.88 | ₹104.32 | ₹77.83 | ₹48.95 |
| Total Expenses | ₹89.76 | ₹100.12 | ₹74.49 | ₹51.01 |
| Profit Before Tax | ₹11.12 | ₹3.96 | ₹3.93 | -₹2.06 |
| Tax | ₹1.84 | ₹0.38 | ₹1.64 | ₹0.31 |
| Profit After Tax | ₹9.28 | ₹3.58 | ₹2.29 | -₹2.37 |
| EPS - Basic | ₹7.26 | ₹3.90 | ₹3.58 | -₹10.28 |
| EPS - Diluted | ₹7.26 | ₹3.90 | ₹3.58 | -₹10.28 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 |
|---|---|---|---|---|
| Profit before tax | ₹11.12 | ₹3.96 | ₹3.93 | -₹2.06 |
| Income before WC changes | ₹17.38 | ₹6.32 | ₹8.25 | ₹1.72 |
| Change in Assets | -₹11.04 | -₹19.77 | ₹3.69 | -₹4.50 |
| Change in Liabilities | -₹9.87 | -₹0.94 | -₹2.12 | ₹2.89 |
| Change in WC | -₹20.91 | -₹20.71 | ₹1.57 | -₹1.61 |
| Cash flow from Operations | -₹4.33 | -₹16.08 | ₹8.14 | -₹0.31 |
| Cash flow from Investing | -₹13.62 | -₹19.68 | -₹11.67 | -₹3.23 |
| Cash flow from Financing | ₹16.09 | ₹29.49 | ₹13.14 | ₹3.38 |
| Total Cash Flow | -₹1.85 | -₹6.26 | ₹9.61 | -₹0.16 |
| Cash (Start of the year) | ₹3.42 | ₹9.68 | ₹0.08 | ₹0.43 |
| Cash (End of the year) | ₹1.56 | ₹3.42 | ₹9.68 | ₹0.27 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 |
|---|---|---|---|---|
| Non-Current Assets | ₹54.50 | ₹44.68 | ₹26.50 | ₹17.35 |
| Current Assets | ₹69.83 | ₹60.65 | ₹47.14 | ₹17.35 |
| Total Assets | ₹124.33 | ₹105.33 | ₹73.64 | ₹34.70 |
| Current Liabilities | ₹51.55 | ₹43.73 | ₹45.81 | ₹22.76 |
| Net Current Asset | ₹18.28 | ₹16.92 | ₹1.33 | -₹5.41 |
| Non-Current Liabilities | ₹14.36 | ₹12.27 | ₹8.14 | ₹9.37 |
| Equity Capital | ₹58.42 | ₹49.33 | ₹19.69 | ₹2.57 |
| Total Equity & Liabilities | ₹124.33 | ₹105.33 | ₹73.64 | ₹34.70 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹62.38 | ₹67.11 | ₹57.98 | ₹73.15 |
| Other Income | ₹2.38 | ₹1.32 | ₹0.24 | ₹0.21 |
| Total Revenue | ₹64.76 | ₹68.42 | ₹58.23 | ₹73.36 |
| Total Expenses | ₹58.34 | ₹60.43 | ₹52.26 | ₹68.67 |
| Profit Before Tax | ₹6.41 | ₹7.76 | ₹5.96 | ₹4.69 |
| Tax | ₹1.64 | ₹2.01 | ₹1.47 | ₹1.39 |
| Profit After Tax | ₹4.77 | ₹5.75 | ₹4.50 | ₹3.30 |
| EPS - Basic | ₹4.32 | ₹5.24 | ₹5.58 | ₹14.33 |
| EPS - Diluted | ₹4.32 | ₹5.24 | ₹5.58 | ₹14.33 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹6.41 | ₹7.76 | ₹5.96 | ₹4.69 |
| Income before WC changes | ₹8.50 | ₹7.97 | ₹8.35 | ₹7.63 |
| Change in Assets | -₹8.35 | -₹19.10 | ₹0.47 | -₹13.46 |
| Change in Liabilities | -₹5.43 | -₹6.93 | ₹1.41 | ₹10.84 |
| Change in WC | -₹13.78 | -₹26.02 | ₹1.87 | -₹2.62 |
| Cash flow from Operations | -₹6.08 | -₹19.75 | ₹8.54 | ₹3.58 |
| Cash flow from Investing | -₹1.89 | -₹12.53 | -₹10.93 | -₹3.28 |
| Cash flow from Financing | ₹7.78 | ₹23.32 | ₹11.97 | -₹0.30 |
| Total Cash Flow | -₹0.20 | -₹8.96 | ₹9.57 | ₹0.00 |
| Cash (Start of the year) | ₹0.64 | ₹9.60 | ₹0.03 | ₹0.02 |
| Cash (End of the year) | ₹0.45 | ₹0.64 | ₹9.60 | ₹0.03 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹30.40 | ₹29.34 | ₹18.18 | ₹8.80 |
| Current Assets | ₹54.90 | ₹46.75 | ₹36.61 | ₹27.50 |
| Total Assets | ₹85.29 | ₹76.09 | ₹54.78 | ₹36.30 |
| Current Liabilities | ₹26.49 | ₹23.28 | ₹27.11 | ₹28.06 |
| Net Current Asset | ₹28.40 | ₹23.47 | ₹9.49 | -₹0.56 |
| Non-Current Liabilities | ₹5.77 | ₹4.53 | ₹6.68 | ₹1.14 |
| Equity Capital | ₹53.03 | ₹48.27 | ₹20.99 | ₹7.10 |
| Total Equity & Liabilities | ₹85.29 | ₹76.09 | ₹54.78 | ₹36.30 |
About SOTAC PHARMACEUTICALS LTD
Sotac Pharmaceuticals Limited is an India-based pharmaceutical company. The Company's services include contract manufacturing, loan license, formulation and development (F & D) and research and development (R & D). It specializes in manufacturing a range of pharmaceutical products having a therapeutic portfolio including anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal and cephalosporin. It also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its products are supplied across 14 states in India, and it exports its products to over 20 countries worldwide. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Lifesciences Private Limited and Sotac Research Private Limited.
SOTAC PHARMACEUTICALS LTD Financial Highlights
- Revenue: SOTAC PHARMACEUTICALS LTD reported revenue of ₹101.59 crore in FY26 vs ₹100.89 crore in FY25. It showed an increase of 0.69% on a yearly basis.
- Operating Profit: SOTAC PHARMACEUTICALS LTD reported an operating profit of ₹8.70 crore in FY26 vs ₹11.12 crore in FY25. It showed a decrease of 21.76% on a year-on-year basis.
- Net Profit: SOTAC PHARMACEUTICALS LTD reported a net profit of ₹6.29 crore in FY26 vs ₹9.28 crore in FY25. It showed a decrease of 32.22% on a yearly basis.
SOTAC PHARMACEUTICALS LTD Quarterly Result Highlights
- SOTAC PHARMACEUTICALS LTD reported revenue of ₹25.50 crore in Jun 2024, compared with ₹26.80 crore in Mar 2024, representing a decrease of 4.85% on a quarter-on-quarter (QoQ) basis.
- SOTAC PHARMACEUTICALS LTD reported an operating profit of ₹1.30 crore in Jun 2024, compared with ₹0.30 crore in Mar 2024, representing an increase of 333.33% on a quarter-on-quarter (QoQ) basis.
- SOTAC PHARMACEUTICALS LTD reported a profit of ₹1.35 crore in Jun 2024, compared with ₹1.51 crore in Mar 2024, reflecting a decrease of 10.60% on a QoQ basis.
- The earnings per share (EPS) of SOTAC PHARMACEUTICALS LTD stood at ₹7.26 during Jun 2024.
Similar Stocks
FAQs on SOTAC PHARMACEUTICALS LTD Share Price
What is SOTAC PHARMACEUTICALS LTD share price today?
SOTAC PHARMACEUTICALS LTD share price is ₹105.00 as on 03 Jul, 2026, 09:48 IST.
How has the SOTAC PHARMACEUTICALS LTD share price performed in the past?
In the last 1 year, SOTAC PHARMACEUTICALS LTD delivered a return of -23.13%. The SOTAC PHARMACEUTICALS LTD share price hit a high of ₹139.65 and low of ₹100.00.
How much is the Mutual Fund shareholding in SOTAC PHARMACEUTICALS LTD shares?
The Mutual Fund Shareholding in SOTAC PHARMACEUTICALS LTD was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of SOTAC PHARMACEUTICALS LTD shares ?
The 52-week high and low of SOTAC PHARMACEUTICALS LTD share is ₹139.65 and ₹100.00 as of 03 Jul, 2026.
What is the market cap of SOTAC PHARMACEUTICALS LTD?
The market capitalisation of SOTAC PHARMACEUTICALS LTD is ₹116.03 Crores as on 03 Jul, 2026.
What are the stock symbols of SOTAC PHARMACEUTICALS LTD?
The stock symbol of SOTAC PHARMACEUTICALS LTD is SOTAC on the NSE, , and the ISIN is INE0O2D01012.
How to buy SOTAC PHARMACEUTICALS LTD shares?
To buy SOTAC PHARMACEUTICALS LTD shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
What was yesterday's closing price for SOTAC PHARMACEUTICALS LTD shares ?
SOTAC PHARMACEUTICALS LTD shares closed yesterday at ₹105.00 on NSE
Can I buy SOTAC PHARMACEUTICALS LTD shares on Holidays?
No, shares of SOTAC PHARMACEUTICALS LTD or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SOTAC PHARMACEUTICALS LTD shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.